biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..